Effectiveness of Artificial Intelligence Integrated Mixed Reality-based High-Alert Medications Management Simulation Program

NCT07390461 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-02-05

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if a Artificial Intelligence integrated Mixed Reality-based High-Alert Medications Management Simulation Program (AIMR-HAM) helps hospital nurses manage high-alert medicines (HAMs) more safely. MR mixes real and virtual elements to let nurses practice in realistic scenarios.

The main questions are:

Does the AIMR-HAM improve nurses' medication safety skills? Does the AIMR-HAM lower medication errors and improve clinical performance?

Researchers will compare two groups to answer these questions:

Intervention group: AIMR-HAM Control group: standard education only

Who can take part:

Nurses who work at large hospitals and have 1 to 6 years of clinical experience.

About 60 nurses will join the study.

What participants will do:

Attend the assigned training (AIMR-HAM or standard education only). Complete short tests and surveys before and after training to measure skills, communication, and clinical reasoning.

Report any medication errors that occur during the study. Why this matters: The study will show whether AIMR-HAM training can improve how nurses handle HAMs and make patient care safer.

Conditions

  • Healhty

Interventions

OTHER

Artificial Intelligence integrated Mixed Reality-based Simulation Program

Participants in the intervention arm receive Artificial Intelligence integrated Mixed Reality-based High-Alert Medications Management Simulation Program

OTHER

Standard medication-management education

Participants receive the hospital's standard medication-management education (didactic lectures, case discussions, and workshops)

Sponsors & Collaborators

  • Chonnam National University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-04
Primary Completion
2026-03-04
Completion
2026-03-06

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07390461 on ClinicalTrials.gov